379 related articles for article (PubMed ID: 29358057)
1. A bivalent vaccine derived from attenuated Salmonella expressing O-antigen polysaccharide provides protection against avian pathogenic Escherichia coli O1 and O2 infection.
Han Y; Liu Q; Willias S; Liang K; Li P; Cheng A; Kong Q
Vaccine; 2018 Feb; 36(8):1038-1046. PubMed ID: 29358057
[TBL] [Abstract][Full Text] [Related]
2. A biologically conjugated polysaccharide vaccine delivered by attenuated Salmonella Typhimurium provides protection against challenge of avian pathogenic Escherichia coli O1 infection.
Han Y; Liu Q; Yi J; Liang K; Wei Y; Kong Q
Pathog Dis; 2017 Nov; 75(8):. PubMed ID: 28911037
[TBL] [Abstract][Full Text] [Related]
3. Regulated delayed attenuation improves vaccine efficacy in preventing infection from avian pathogenic Escherichia coli O
Han Y; Luo P; Chen Y; Xu J; Sun J; Guan C; Wang P; Chen M; Zhang X; Zhu Y; Zhu T; Zhai R; Cheng C; Song H
Vet Microbiol; 2021 Mar; 254():109012. PubMed ID: 33611126
[TBL] [Abstract][Full Text] [Related]
4. Construction and evaluation of a delta cya delta crp Salmonella typhimurium strain expressing avian pathogenic Escherichia coli O78 LPS as a vaccine to prevent airsacculitis in chickens.
Roland K; Curtiss R; Sizemore D
Avian Dis; 1999; 43(3):429-41. PubMed ID: 10494411
[TBL] [Abstract][Full Text] [Related]
5. Recombinant Iss as a potential vaccine for avian colibacillosis.
Lynne AM; Kariyawasam S; Wannemuehler Y; Johnson TJ; Johnson SJ; Sinha AS; Lynne DK; Moon HW; Jordan DM; Logue CM; Foley SL; Nolan LK
Avian Dis; 2012 Mar; 56(1):192-9. PubMed ID: 22545546
[TBL] [Abstract][Full Text] [Related]
6. Construction of an attenuated Salmonella delivery system harboring genes encoding various virulence factors of avian pathogenic Escherichia coli and its potential as a candidate vaccine for chicken colibacillosis.
Chaudhari AA; Matsuda K; Lee JH
Avian Dis; 2013 Mar; 57(1):88-96. PubMed ID: 23678735
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity in chickens with orally administered recombinant chicken-borne Lactobacillus saerimneri expressing FimA and OmpC antigen of O78 avian pathogenic Escherichia coli.
Ma ST; Ding GJ; Huang XW; Wang ZW; Wang L; Yu ML; Shi W; Jiang YP; Tang LJ; Xu YG; Li YJ
J Med Microbiol; 2018 Mar; 67(3):441-451. PubMed ID: 29458539
[TBL] [Abstract][Full Text] [Related]
8. Expression of Escherichia coli antigens in Salmonella typhimurium as a vaccine to prevent airsacculitis in chickens.
Roland K; Karaca K; Sizemore D
Avian Dis; 2004 Sep; 48(3):595-605. PubMed ID: 15529982
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the adjuvant effect of Salmonella-based Escherichia coli heat-labile toxin B subunits on the efficacy of a live Salmonella-delivered avian pathogenic Escherichia coli vaccine.
Chaudhari AA; Lee JH
Avian Pathol; 2013 Aug; 42(4):365-72. PubMed ID: 23815619
[TBL] [Abstract][Full Text] [Related]
10. A recombinant multi-antigen vaccine with broad protection potential against avian pathogenic Escherichia coli.
Van Goor A; Stromberg ZR; Mellata M
PLoS One; 2017; 12(8):e0183929. PubMed ID: 28837660
[TBL] [Abstract][Full Text] [Related]
11. Protection against avian pathogenic Escherichia coli and Salmonella Kentucky exhibited in chickens given both probiotics and live Salmonella vaccine.
Redweik GAJ; Stromberg ZR; Van Goor A; Mellata M
Poult Sci; 2020 Feb; 99(2):752-762. PubMed ID: 32029160
[TBL] [Abstract][Full Text] [Related]
12. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC
Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779
[TBL] [Abstract][Full Text] [Related]
13. Two Novel
Zhao X; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Sun K; Yang Q; Wu Y; Cheng A
Front Cell Infect Microbiol; 2017; 7():391. PubMed ID: 28929089
[TBL] [Abstract][Full Text] [Related]
14. Immunization with outer membrane vesicles of avian pathogenic Escherichia coli O78 induces protective immunity in chickens.
Wang H; Liang K; Kong Q; Liu Q
Vet Microbiol; 2019 Sep; 236():108367. PubMed ID: 31500727
[TBL] [Abstract][Full Text] [Related]
15. Design, development, and evaluation of the efficacy of a nucleic acid-free version of a bacterial ghost candidate vaccine against avian pathogenic E. coli (APEC) O78:K80 serotype.
Soleymani S; Tavassoli A; Hashemi Tabar G; Kalidari GA; Dehghani H
Vet Res; 2020 Dec; 51(1):144. PubMed ID: 33298146
[TBL] [Abstract][Full Text] [Related]
16. Exploiting bacterial outer membrane vesicles as a cross-protective vaccine candidate against avian pathogenic Escherichia coli (APEC).
Hu R; Li J; Zhao Y; Lin H; Liang L; Wang M; Liu H; Min Y; Gao Y; Yang M
Microb Cell Fact; 2020 Jun; 19(1):119. PubMed ID: 32493405
[TBL] [Abstract][Full Text] [Related]
17. Bacterial ghost of avian pathogenic E. coli (APEC) serotype O78:K80 as a homologous vaccine against avian colibacillosis.
Ebrahimi-Nik H; Bassami MR; Mohri M; Rad M; Khan MI
PLoS One; 2018; 13(3):e0194888. PubMed ID: 29566080
[TBL] [Abstract][Full Text] [Related]
18. Safety, immunogenicity, and efficacy of two Escherichia coli cya crp mutants as vaccines for broilers.
Peighambari SM; Hunter DB; Shewen PE; Gyles CL
Avian Dis; 2002; 46(2):287-97. PubMed ID: 12061637
[TBL] [Abstract][Full Text] [Related]
19. A cyclophosphamide-sensitive cell compartment is essential for homologous protection conferred by licensed vaccines for the control of avian pathogenic Escherichia coli in chickens.
Sadeyen JR; Kaiser P; Stevens MP; Dziva F
Vaccine; 2015 Jul; 33(31):3624-7. PubMed ID: 26087298
[TBL] [Abstract][Full Text] [Related]
20. Advances in vaccination against avian pathogenic Escherichia coli respiratory disease: potentials and limitations.
Ghunaim H; Abu-Madi MA; Kariyawasam S
Vet Microbiol; 2014 Aug; 172(1-2):13-22. PubMed ID: 24878325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
